These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37256621)

  • 1. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Gentle SJ; Rysavy MA; Li L; Laughon MM; Patel RM; Jensen EA; Hintz S; Ambalavanan N; Carlo WA; Watterberg K;
    JAMA Netw Open; 2023 May; 6(5):e2315315. PubMed ID: 37256621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparing the prognostic value of 3 diagnostic criteria of bronchopulmonary dysplasia in preterm infants].
    Wang X; Guo J; Wu YY; Lu YK; Liu DP; Li MC; Li R; Wang YY; Kang WQ
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):36-42. PubMed ID: 38154975
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.
    Watterberg KL; Walsh MC; Li L; Chawla S; D'Angio CT; Goldberg RN; Hintz SR; Laughon MM; Yoder BA; Kennedy KA; McDavid GE; Backstrom-Lacy C; Das A; Crawford MM; Keszler M; Sokol GM; Poindexter BB; Ambalavanan N; Hibbs AM; Truog WE; Schmidt B; Wyckoff MH; Khan AM; Garg M; Chess PR; Reynolds AM; Moallem M; Bell EF; Meyer LR; Patel RM; Van Meurs KP; Cotten CM; McGowan EC; Hines AC; Merhar S; Peralta-Carcelen M; Wilson-Costello DE; Kilbride HW; DeMauro SB; Heyne RJ; Mosquera RA; Natarajan G; Purdy IB; Lowe JR; Maitre NL; Harmon HM; Hogden LA; Adams-Chapman I; Winter S; Malcolm WF; Higgins RD;
    N Engl J Med; 2022 Mar; 386(12):1121-1131. PubMed ID: 35320643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB;
    JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; van de Loo M; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
    Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.
    Rysavy MA; Li L; Tyson JE; Jensen EA; Das A; Ambalavanan N; Laughon MM; Greenberg RG; Patel RM; Pedroza C; Bell EF;
    J Pediatr; 2021 Sep; 236():78-85.e5. PubMed ID: 34004189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial.
    Starr MC; Griffin R; Gist KM; Segar JL; Raina R; Guillet R; Nesargi S; Menon S; Anderson N; Askenazi DJ; Selewski DT;
    JAMA Netw Open; 2022 Dec; 5(12):e2248826. PubMed ID: 36580332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.
    Jensen EA; Laughon MM; DeMauro SB; Cotten CM; Do B; Carlo WA; Watterberg KL
    Semin Perinatol; 2022 Nov; 46(7):151638. PubMed ID: 36085059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial.
    Colaizy TT; Poindexter BB; McDonald SA; Bell EF; Carlo WA; Carlson SJ; DeMauro SB; Kennedy KA; Nelin LD; Sánchez PJ; Vohr BR; Johnson KJ; Herron DE; Das A; Crawford MM; Walsh MC; Higgins RD; Stoll BJ; ; ; Ambalavanan N; Wyckoff MH; D'Angio CT; Bugg GW; Ohls RK; Reynolds AM; Sokol GM; Laptook AR; Olsen SL; White JR; Jadcherla SR; Bajaj M; Parimi PS; Schmidt B; Laughon MM; Barks J; Fisher KA; Hibbs AM; Peralta-Carcelen M; Cook N; Heyne RJ; Cavanaugh B; Adams-Chapman I; Fuller J; Hartley-McAndrew ME; Harmon HM; Duncan AF; Hines AC; Kilbride HW; Richards LA; Maitre NL; Natarajan G; Trembath AN; Carlson MD; Malcolm WF; Wilson-Costello DE; ;
    JAMA; 2024 Feb; 331(7):582-591. PubMed ID: 38497706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
    Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.